iCareDx Announces Appointment Of Advisory Board
iCareDx, Inc., a biotechnology company focused on blood-based early detection of cancer, today announced the formation of an Advisory Board, comprised of renowned scientists, clinicians and business leaders in the areas of oncology and diagnostics. The Advisory Board’s role will be to provide valuable scientific, clinical and business insights, along with strategic guidance in decision-making, as the Company seeks to advance its blood-based screening tests for early detection of colorectal cancer as well as for early detection in pan-oncology.
“We are honored to welcome such outstanding authorities in their respective areas to our advisory board to support the development of iCareDx's early detection screening technologies,” said Dr. Bernard Peperstraete, the Chief Executive Officer of iCareDx. “In forming the company’s inaugural Advisory Board, we are seeking to further position iCareDx to successfully pursue a highly accurate and cost-effective approach for early cancer detection, and to ultimately help reduce cancer deaths.”
Over the past years, the design of iCareDx's molecular detection technologies was led by Francis Barany, PhD, Professor of Microbiology and Immunology at the Weill Cornell Medicine. Dr. Barany is a prolific inventor with 52 issued US patents, which are foundational inventions in molecular diagnostics and next generation sequencing, and include the ligase chain reaction (LCR), the ligase detection reaction (LDR), and the Universal DNA array. “We have assembled this team of thought leaders to guide our efforts in advancing our platform for blood-based early cancer detection,” said Dr. Francis Barany. “Our scalable, low-cost cancer detection platforms are designed to vastly improve cancer care, ultimately throughout the world.”
Composition of iCareDx's Advisory Board:
- Mr. Haywood Cochrane. Previously, CEO at CHD Meridian Corp (now part of Walgreens), at Allied Clinical Labs and at Take Care Employer Solutions; EVP, CFO and Treasurer at LabCorp, COO at Biomedical Reference Labs, SVP North-America Diagnostics and COO at Roche Biomedical labs; Director at Tripath Imaging, American Esoteric Labs, Sonus Corp., Ameripath, Unilab Corp.
- Dr. Paolo Fortina. Professor of Cancer Biology and Medical Oncology at the Sidney Kimmel Medical College, Director of the NCI-designated Cancer Genomics Laboratory at the Sidney Kimmel Cancer Center, Thomas Jefferson University.
- Dr. David Gelfand. Previously, Vice President, Discovery Research Division and Director for the Program in Core Research at Roche Molecular Systems, CSO of WaferGen BioSystems, and a consultant at the Centre National de Génotypage in France, inventor of the real-time PCR (“TaqMan”) technology and many thermostable DNA Polymerases and Reverse Transcriptases.
- Dr. Larry J. Kricka. Professor of Pathology & Laboratory Medicine at the University of Pennsylvania Director of the General Chemistry and Endocrinology Laboratory at the Hospital of the University of Pennsylvania.
- Dr. Christopher Mason. Associate Professor Computational Genomics at Weill Cornell Medicine, with appointments at Department of Physiology and Biophysics, Institute for Computational Biomedicine, Meyer Cancer Center, Feil Family Brain and Mind Research Institute. WorldQuant Foundation Research Scholar. Affiliate Fellow of Genomics, Ethics, and Law, ISP, Yale Law School.
- Dr. Kenneth Offit. Chief of Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, Member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, Professor of Medicine and Public Health at the Weill Cornell Medicine.
- Dr. Mark Pochapin. Sholtz/Leeds Professor, Director of Gastroenterology, Professor of Medicine at NYU Langone Medical Center. Advanced gastrointestinal endoscopy, and the prevention, early detection, and treatment of gastrointestinal cancers.
About iCareDx Inc.
iCareDx is a biotechnology company focused on developing technologies for blood-based early detection of cancer. iCareDx's technology allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team, it is iCareDx’s mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.
Chief Executive Officer
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Hisense's Zhou Houjian and Huawei's Kevin Ho to Keynote CES Asia; Focus on Mobility, 5G and Connectivity24.5.2018 15:00 | Pressemelding
The Consumer Technology AssociationTM (CTA) today announced that Hisense Chairman Zhou Houjian and Huawei’s president of Handset Product Line Kevin Ho will deliver separate keynote addresses at the upcoming CES AsiaTM 2018. As CES Asia drives the expansion of technology into new areas like artificial intelligence, vehicle technology, AR, VR and more, Chairman Zhou and Mr. Ho will discuss the future of innovation at their respective companies through connectivity and mobility during Asia’s premier tech event. “Hisense and Huawei have become major global brands by challenging the status quo and creating innovative product solutions that engage, entertain and connect consumers around the world,” said Gary Shapiro, president and CEO, CTA. “We are thrilled to welcome Chairman Zhou and Mr. Ho to the CES Asia keynote stage and are eager to learn from these experts who are leading the charge to harness the potential of 5G through various implementation strategies and connection opportunities.”
Maximum Cryptocurrencies Available for EU Traders in Libertex24.5.2018 14:29 | Pressemelding
Libertex trading platform, operated by Indication Investments Ltd, announces that starting from May 23rd 2018, European traders can perform operations with 34 new cryptocurrency CFD instruments. This means that Libertex became one of the leading applications and trading platforms for EU traders in terms of amount of cryptocurrencies available. Andrew Nikolaev, Libertex Executive director highlighted: “Cryptocurrencies are one of the main trends in financial industry for the past couple of years. The demand for these assets grows significantly. We are happy to satisfy the demand of European traders for new innovative crypto-instruments launching them in our cutting edge Libertex platform”. Launch of cryptocurrency pairs in Libertex for EU traders follows Circular from Cyprus financial regulator - CySec issued on May 15th 2018, that introduces new rules for governing derivatives on virtual currencies. According to this Circular, CFDs on virtual currencies are considered as financial inst
Andersen Global’s Middle East Expansion Continues with Solutions Bridge in Kuwait24.5.2018 13:30 | Pressemelding
Solutions Bridge, an Accounting and Corporate Secretarial Services firm in Kuwait City, has signed a Collaboration Agreement with Andersen Global. The addition of a location in Kuwait demonstrates Andersen Global’s growth in the Middle East, which is a significant market for the organization. “Having a strong practice in Kuwait is important to our regional success and this is an extraordinary opportunity to continue providing best-in-class services globally,” commented Mark Vorsatz, Global Chairman and Andersen Tax LLC CEO. “There are many changes in the Middle East currently and the development of tax laws is a major factor in the region. The addition of Solutions Bridge, one of the largest accounting firms in Kuwait, positions us for continued opportunities for expansion.” Formed by former professionals of Andersen in Kuwait, Solutions Bridge is led by Partner Fouad Al Hourani. The firm provides accounting and corporate secretarial services for both individuals and corporations in a
Workiva Signs OEM Agreement with SAP to Offer SAP® Cloud Platform Integration with the Workiva Wdesk Platform24.5.2018 13:00 | Pressemelding
Workiva (NYSE:WK), a leader in cloud-based data collaboration, reporting and compliance solutions, today announced it has signed an original equipment manufacturer (OEM) agreement with SAP (NYSE:SAP). Through this agreement, Workiva is partnering with SAP to provide a first-party integration with the Wdesk platform using the SAP® Cloud Platform Integration service. The bundled solutions are expected to provide customers with powerful linking, auditability and control features. “Today’s announcement demonstrates that Workiva and SAP are committed to providing customers with a rich integration experience,” said Matt Rizai, chairman and CEO of Workiva. “Through our OEM partnership, we will help customers all over the world improve the value of their business data.” After users integrate their SAP business data directly into the Wdesk platform, they can benefit from the full capabilities of Wdesk, including synchronized data, dynamic commentary, controlled collaboration, granular permissio
M-Brain Appoints New CEO24.5.2018 12:25 | Pressemelding
M-Brain, a global leader in market and media intelligence solutions, has appointed Christian Cedercreutz Chief Executive Officer as of 13.8.2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180524005676/en/ M-Brain, a global leader in market and media intelligence solutions, has appointed Christian Cedercreutz Chief Executive Officer as of 13.8.2018. (Photo: Business Wire) Christian holds a Master of Economics degree from Hanken School of Economics in Helsinki. His career has been built with IBM over the past 20 years, in which he has held various management positions in five different European countries. Christian brings strong consultative selling experience and has over the years worked across the IBM Corporation in roles such as leading global client relationships, and leading SW and HW technology businesses in Finland. His most recent role has been to lead the cognitive SW solutions (Watson) business in Finland. Simu
IBIN Introduced into Billion Dollar Blockchain Market by Hybrid Stock Exchange24.5.2018 12:13 | Pressemelding
Hybrid Stock Exchange, a blockchain based trading platform using the released IBIN as a blockshare identifier, are all set to adopt innovative features to sustain the needs of the ever growing industry. Watch the HYBSE trailer here: http://www.hybse.com The International Securities Identification Number (ISIN) is a 12 character code that uniquely identifies a specific security, such as stocks, and is the most popular global securities identifier. With the pre-registration for issuers and users opened, the DIM Ecosystem introduces the International Blockshare Identification Number (IBIN), a 13 digit, unique serial number used by a company for listing on the Hybrid Stock Exchange or other Blockchain Exchanges. Tradable securities on HYBSE currently include Cryptonized equity, Cryptocurrencies, Exchange-traded commodities, index, and more. Any issuers are able to apply for their IBIN at no charge. This limited time offer is available until August 31, 2018 or for the first 75 companies tha